サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1674034

結核診断の世界市場レポート 2025年

Tuberculosis Diagnostics Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
結核診断の世界市場レポート 2025年
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

結核診断市場規模は、今後数年間で力強い成長が見込まれます。2029年には32億4,000万米ドルに成長し、CAGRは8.2%となります。予測期間の成長は、政府の強力な支援、FDAによる結核診断薬の承認の増加、研究開発（R&D）活動の活発化、薬剤耐性結核の出現に起因すると考えられます。予測期間における主な動向としては、結核診断のための次世代シークエンシング（NGS）プラットフォームへの注目、製品イノベーション、結核感染のためのt細胞検査、人工知能（AI）ベースの結核診断薬、携帯機器の使用、政府とメーカーのコラボレーションなどが挙げられます。

結核罹患率の増加が結核診断市場の需要を押し上げています。結核は主に肺を侵す重篤な感染症であり、咳やくしゃみによって小さな細菌が空気中に放出されることで感染します。効果的な結核診断薬は、この病気の早期発見・診断に重要な役割を果たします。例えば、2023年3月、米国を拠点とする国の公衆衛生機関である疾病対策予防センター（CDC）は、2022年の米国における結核患者数が8,300人となり、2021年の7,874人から増加したと報告しました。この結核患者の増加が結核診断市場の成長を牽引しています。

米国食品医薬品局（FDA）による結核診断薬の承認件数の増加は、市場の成長をさらに後押しすると思われます。その一例として、2023年3月に英国の医療診断会社であるPerkinElmer Oxford Immunotec社が、Allsheng Instruments社製のAuto-Pure 24およびAuto-Pure 20Bプラットフォームという2つの細胞分離装置を追加使用するFDA承認を取得したと発表したことが挙げられます。さらに、2022年10月、パーキンエルマー・オックスフォード・イムノテックは、T-Cell Select試薬キットの使用についてFDAの承認を取得し、認定検査室による体外診断（IVD）用T-SPOT.TB検査ワークフローの自動化を促進しました。末梢血単核球（PBMC）分離試薬であるT-Cell Selectは、磁気ビーズベースの細胞分離によるPBMCのポジティブセレクションを採用しており、T-SPOT.TB検査（潜伏結核感染を検出するために設計された国際的に規制されたELISPOT IGRA）用の細胞の製剤を効率化します。このような新規の結核診断薬に対するFDA承認の流入は、結核診断市場の成長を強化し、促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界結核診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の結核診断市場：成長率分析
  • 世界の結核診断市場の実績：規模と成長, 2019-2024
  • 世界の結核診断市場の予測：規模と成長, 2024-2029, 2034F
  • 世界の結核診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の結核診断市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 放射線検査
  • 核酸検査
  • サイトカイン検出検査
  • 薬剤耐性検査
  • 皮膚テスト/マントーテスト（TST）
  • 血液/血清検査
  • 塗抹顕微鏡検査
  • 細胞培養に基づく検査
  • その他のテストの種類
  • 世界の結核診断市場病気のステージ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 潜在性結核
  • 活動性結核
  • 世界の結核診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院および診断研究所
  • 医師のオフィスの検査室
  • リファレンスラボ
  • 学術調査施設
  • 世界の結核診断市場、放射線検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 胸部X線検査
  • CTスキャン
  • 世界の結核診断市場核酸検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ポリメラーゼ連鎖反応（PCR）
  • 核酸増幅検査（NAAT）
  • 世界の結核診断市場サイトカイン検出検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • インターフェロンガンマ放出アッセイ（IGRA）
  • 世界の結核診断市場薬剤耐性検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • GeneXpert MTB/RIF
  • ラインプローブアッセイ
  • 世界の結核診断市場、皮膚テスト/マントーテスト（TST）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ツベルクリン皮膚テスト（TST）
  • 世界の結核診断市場、血液/血清検査のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗体の血清学的検査
  • 世界の結核診断市場、塗抹顕微鏡検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗酸菌（AFB）塗抹検査
  • 世界の結核診断市場細胞培養ベースの検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ソリッドメディアカルチャー
  • 液体培地培養
  • 世界の結核診断市場、その他のテストタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 分子検査
  • 高度な画像技術

第7章 地域別・国別分析

  • 世界の結核診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の結核診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 結核診断市場：競合情勢
  • 結核診断市場：企業プロファイル
    • Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • PerkinElmer
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad Laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • Siemens AG
  • LumiraDx Limited
  • TestLine Clinical Diagnostics s.r.o.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 結核診断市場2029：新たな機会を提供する国
  • 結核診断市場2029：新たな機会を提供するセグメント
  • 結核診断市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r26008

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

The increasing incidence of tuberculosis is boosting demand for the tuberculosis diagnostics market. Tuberculosis is a severe infectious disease primarily affecting the lungs and is transmitted through coughing and sneezing, which release tiny germs into the air. Effective tuberculosis diagnostics play a crucial role in early detection and diagnosis of the disease. For example, in March 2023, the Centers for Disease Control and Prevention (CDC), a US-based national public health organization, reported 8,300 cases of tuberculosis (TB) in the United States in 2022, up from 7,874 cases in 2021. This rise in tuberculosis cases is driving growth in the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Tuberculosis Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tuberculosis Diagnostics Market Growth Rate Analysis
  • 5.4. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tuberculosis Diagnostics Total Addressable Market (TAM)

6. Tuberculosis Diagnostics Market Segmentation

  • 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiographic Tests
  • Nucleic Acid Testing
  • Cytokine Detection Tests
  • Drug Resistance Tests
  • Skin Test / Mantoux Test (TST)
  • Blood/Serology Test
  • Smear Microscopy Tests
  • Cell Culture-Based Tests
  • Other Test Types
  • 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Latent Tuberculosis
  • Active Tuberculosis
  • 6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Academics And Research Facilities
  • 6.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chest X-rays
  • CT Scans
  • 6.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Tests (NAATs)
  • 6.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 6.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GeneXpert MTB/RIF
  • Line Probe Assays
  • 6.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tuberculin Skin Test (TST)
  • 6.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests for Antibodies
  • 6.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 6.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Media Cultures
  • Liquid Media Cultures
  • 6.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Tests
  • Advanced Imaging Techniques

7. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

  • 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tuberculosis Diagnostics Market

  • 9.1. China Tuberculosis Diagnostics Market Overview
  • 9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tuberculosis Diagnostics Market

  • 10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tuberculosis Diagnostics Market

  • 11.1. Japan Tuberculosis Diagnostics Market Overview
  • 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tuberculosis Diagnostics Market

  • 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

  • 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

  • 14.1. South Korea Tuberculosis Diagnostics Market Overview
  • 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

  • 15.1. Western Europe Tuberculosis Diagnostics Market Overview
  • 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tuberculosis Diagnostics Market

  • 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tuberculosis Diagnostics Market

  • 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tuberculosis Diagnostics Market

  • 18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tuberculosis Diagnostics Market

  • 19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tuberculosis Diagnostics Market

  • 20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

  • 21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • 21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tuberculosis Diagnostics Market

  • 22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tuberculosis Diagnostics Market

  • 23.1. North America Tuberculosis Diagnostics Market Overview
  • 23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tuberculosis Diagnostics Market

  • 24.1. USA Tuberculosis Diagnostics Market Overview
  • 24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tuberculosis Diagnostics Market

  • 25.1. Canada Tuberculosis Diagnostics Market Overview
  • 25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tuberculosis Diagnostics Market

  • 26.1. South America Tuberculosis Diagnostics Market Overview
  • 26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

  • 27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

  • 28.1. Middle East Tuberculosis Diagnostics Market Overview
  • 28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tuberculosis Diagnostics Market

  • 29.1. Africa Tuberculosis Diagnostics Market Overview
  • 29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Tuberculosis Diagnostics Market Competitive Landscape
  • 30.2. Tuberculosis Diagnostics Market Company Profiles
    • 30.2.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Creative Diagnostics
  • 31.4. Lionex GmbH
  • 31.5. Biocartis
  • 31.6. Bio-Techne India Private Limited
  • 31.7. Bio-Rad Laboratories India Pvt.Ltd
  • 31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
  • 31.9. ADICON Clinical Laboratories
  • 31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.11. Kindstar Global
  • 31.12. OriGene Technologies
  • 31.13. Siemens AG
  • 31.14. LumiraDx Limited
  • 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

34. Recent Developments In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Tuberculosis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tuberculosis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tuberculosis Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer